-
Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM)
-
Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.
-
Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level
-
Prediction of early-stage Parkinson’s disease using connectivity and morphometry of the striatum
-
Predictive factors for a favorable STN-DBS outcome in Parkinson’s Disease: the role of axial symptoms
-
Predictors of loss to follow-up three years after inclusion in a prospective longitudinal cohort study in people with early Parkinson’s disease
-
Predictors of relapse in impulse control disorders in patients with Parkinson’s disease.
-
Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease
-
Predictors of the change in burden and strain among caregivers of Parkinson’s disease patients
-
Preferences for discussing sexual health concerns
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 153
- Next Page »